Abiopharma

🔍 Griselli Alberto Mario (Executive)

Company: TIM S.A. (TIMB)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 397,022 shares of Common Shares (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: false | shares_owned_after: 617,781.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 99,692 shares of Common Shares (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: false | shares_owned_after: 717,473.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the number of common shares earned (including any accrued dividend equivalent units), as a result of the Issuer's Board of Director's (the "Board") certification to the achievement of performance for the performance shares granted in 2023. These shares vest 20%, 30% and 50% on the first three anniversaries of the grant date, respectively, subject to the Reporting Person's continued service through each such vesting date.
• F2: Represents the number of common shares earned (including any accrued dividend equivalent units), as a result of the Board's certification to the achievement of performance for portions of the performance shares granted in 2024. These shares vest 10%, 20% and 70% on the first three anniversaries of the grant date, respectively, subject to the Reporting Person's continued service through each such vesting date.